Fluoxetine
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292011This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C17H18F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01K63SUP8D, chemically known as (+) or (-)-n-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine but generally known as fluoxetine, which bears US NIH Compound Identifier 3386. European Medicines Agency schedules Fluoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07723MIG. The term FLUOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules fluoxetine in its Anatomical Therapeutic Chemical (ATC) Classification. FLUOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluoxetine under HS 29221980 and SITC 51461. As of Q4 2014, FLUOXETINE remains the US FDA Preferred Term for this commodity. Fluoxetine bears US NLM identifiers UMLS ID C0016365 and NCI Concept Code C506. SMILES: FC(F)(F)c1ccc(OC(CCNC)c2ccccc2)cc1.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.